TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment

Bibliographic Details
Main Author: Koichi Akashi
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920301334
_version_ 1818389059557392384
author Koichi Akashi
author_facet Koichi Akashi
author_sort Koichi Akashi
collection DOAJ
first_indexed 2024-12-14T04:35:43Z
format Article
id doaj.art-5b2b92bc16a842ca812eff89c098fcb5
institution Directory Open Access Journal
issn 2531-1379
language English
last_indexed 2024-12-14T04:35:43Z
publishDate 2020-10-01
publisher Elsevier
record_format Article
series Hematology, Transfusion and Cell Therapy
spelling doaj.art-5b2b92bc16a842ca812eff89c098fcb52022-12-21T23:16:58ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-10-01421TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatmentKoichi Akashihttp://www.sciencedirect.com/science/article/pii/S2531137920301334
spellingShingle Koichi Akashi
TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
Hematology, Transfusion and Cell Therapy
title TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
title_full TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
title_fullStr TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
title_full_unstemmed TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
title_short TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
title_sort tim 3 gal 9 signaling is the molecular target for human myeloid leukemia treatment
url http://www.sciencedirect.com/science/article/pii/S2531137920301334
work_keys_str_mv AT koichiakashi tim3gal9signalingisthemoleculartargetforhumanmyeloidleukemiatreatment